RAS consists of KRAS, NRAS and HRAS, and mutations in these genes have been frequently reported in colorectal cancer, pancreatic ductal adenocarcinoma, lung adenocarcinoma, melanoma and some hematological cancers [6]. This evidence concerns the gene NRAS and lung adenocarcinoma.